Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- UtoBrain Seminae
January 8, 2007
- No NHI Price Revision in FY2007: Chuikyo
January 8, 2007
- Gov't Approves 2.5% Budget Increase for Korosho
January 8, 2007
- Council to Begin Drafting Innovation 25 Strategy
January 8, 2007
- REGULATORY NEWS IN BRIEF
January 8, 2007
- STATISTICS
January 8, 2007
- 72% of Smokers Unaware of Insurance Coverage for Smoking Cessation: Novartis
January 8, 2007
- Mr Uchida of ABMJ Expresses High Expectations of Vaccine Study Group
January 8, 2007
- Metabolic Syndrome, Not Alcohol Consumption, Contributes to ALT Elevation
January 8, 2007
- R&D NEWS IN BRIEF
January 8, 2007
- Japan Ranks 5th Among OECD Countries in Health: JPC-SED
January 8, 2007
- JACDS to Review Relationship with JPA
January 8, 2007
- Risk Classification for OTC Drugs Nearly Complete: PFSB
December 25, 2006
- Transfer Price Taxation System to Be Revised in FY2007
December 25, 2006
- Asahi Kasei Medical, Kuraray Medical to Integrate Businesses
December 25, 2006
- Tie-ups of Hansha Spreading to Kanto, Shikoku: Mr Eguchi
December 25, 2006
- MEDICAL DEVICE NEWS IN BRIEF
December 25, 2006
- Korosho Exchanges Opinions with NPhA on Generics, Distribution
December 25, 2006
- Financial Support to Be Provided to Fewer Patients with Ulcerative Colitis, Parkinson's Disease
December 25, 2006
- JGPMA Proposes "Drug Benefit Standard Price System"
December 25, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…